First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia
- 30 September 2008
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 199 (3), 266.e1-266.e6
- https://doi.org/10.1016/j.ajog.2008.06.069
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Evaluation of physiological alterations of the placenta through analysis of cell-free messenger ribonucleic acid concentrations of angiogenic factorsAmerican Journal of Obstetrics and Gynecology, 2008
- Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2007
- Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancyAmerican Journal of Obstetrics and Gynecology, 2007
- Sequential Changes in Antiangiogenic Factors in Early Pregnancy and Risk of Developing PreeclampsiaHypertension, 2007
- Serum markers for predicting pre-eclampsiaMolecular Aspects of Medicine, 2007
- First Trimester Markers for Pre-Eclampsia: Placental vs. Non-Placental Protein Serum LevelsGynecologic and Obstetric Investigation, 2006
- Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2005
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004
- Second‐ and third‐trimester serum levels of placental proteins in preeclampsia and small‐for‐gestational age pregnanciesActa Obstetricia et Gynecologica Scandinavica, 2003
- Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free β-hCG levelsPrenatal Diagnosis, 1999